GlobalFoundries (GFS) partners with Taiwan Semiconductor (TSM) to license advanced GaN technology for US-based manufacturing of power chips.
AnaptysBio ends its ulcerative colitis trial after rosnilimab misses key goals, focusing resources on rheumatoid arthritis and future programs.
Maplebear Inc., operating as Instacart, delivers strong Q3 results, raises outlook despite competition in grocery delivery.
Zscaler (ZS) is predicted to continue its success, with demand for its Zero Trust and AI security products growing. Analyst Ives maintains an Outperform rating and raises price target to $350.
Galecto stock jumps after acquiring Damora Therapeutics and raising $285 million to advance blood cancer programs through 2029.
Venture Global (NYSE: VG) shares rose after reporting revenue of $3.33 billion, up 260% Y/Y, but EPS of 16 cents missed estimates.